Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,954 | 630 | 99.8% |
| Education | $16.02 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $936.55 | 115 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $889.65 | 31 | $0 (2021) |
| Novo Nordisk Inc | $764.63 | 59 | $0 (2023) |
| ABBVIE INC. | $597.65 | 36 | $0 (2023) |
| GlaxoSmithKline, LLC. | $540.57 | 40 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $509.48 | 51 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $442.01 | 29 | $0 (2023) |
| Lilly USA, LLC | $429.95 | 43 | $0 (2023) |
| Merck Sharp & Dohme LLC | $361.80 | 45 | $0 (2022) |
| Amgen Inc. | $337.83 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.80 | 1 | Abbott Laboratories ($15.80) |
| 2023 | $595.69 | 33 | ABBVIE INC. ($200.37) |
| 2022 | $506.75 | 30 | ABBVIE INC. ($72.77) |
| 2021 | $773.25 | 52 | AbbVie Inc. ($186.39) |
| 2020 | $497.63 | 33 | AstraZeneca Pharmaceuticals LP ($151.00) |
| 2019 | $1,659 | 138 | AstraZeneca Pharmaceuticals LP ($285.93) |
| 2018 | $1,893 | 164 | PFIZER INC. ($354.73) |
| 2017 | $2,030 | 182 | Novo Nordisk Inc ($267.17) |
All Payment Transactions
633 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes Care | ||||||
| 12/18/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes Care | ||||||
| 11/20/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes Care | ||||||
| 08/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation | ||||||
| 08/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 07/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Diabetes Care | ||||||
| 06/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 05/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardio-renal | ||||||
| 05/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DIABETES | ||||||
| 05/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: VACCINES | ||||||
| 04/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardio-renal | ||||||
| 04/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 03/30/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $46.60 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 345 | 517 | $102,541 | $19,305 |
| 2022 | 13 | 636 | 1,088 | $160,930 | $39,028 |
| 2021 | 24 | 922 | 1,327 | $186,201 | $72,594 |
| 2020 | 20 | 885 | 1,278 | $167,383 | $58,533 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 367 | $66,060 | $14,632 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $21,725 | $1,490 | 6.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 13 | $2,366 | $1,193 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 26 | $3,510 | $997.19 | 28.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $7,905 | $640.21 | 8.1% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 14 | 15 | $975.00 | $352.95 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 475 | $84,233 | $20,927 | 24.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 59 | 62 | $6,820 | $4,240 | 62.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 29 | 35 | $15,885 | $2,161 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 54 | $6,858 | $1,962 | 28.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,240 | $1,913 | 59.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 67 | $2,546 | $1,807 | 71.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $7,410 | $1,710 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $26,877 | $1,688 | 6.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 40 | 40 | $3,600 | $1,426 | 39.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 14 | 14 | $1,260 | $502.64 | 39.9% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2022 | 13 | 15 | $975.00 | $414.31 | 42.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 176 | $704.00 | $148.89 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $522.00 | $128.92 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 554 | $95,842 | $27,198 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 122 | 122 | $22,936 | $15,451 | 67.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 25 | 27 | $10,900 | $5,571 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 123 | $14,721 | $4,392 | 29.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 56 | 56 | $6,160 | $3,589 | 58.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $4,050 | $2,422 | 59.8% |
About Dr. Simon Lovasco, M.D
Dr. Simon Lovasco, M.D is a Family Medicine healthcare provider based in Taylor Mill, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083978019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Lovasco, M.D has received a total of $7,970 in payments from pharmaceutical and medical device companies, with $15.80 received in 2024. These payments were reported across 633 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,954).
As a Medicare-enrolled provider, Lovasco has provided services to 2,788 Medicare beneficiaries, totaling 4,210 services with total Medicare billing of $189,460. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Taylor Mill, KY
- Active Since 06/25/2012
- Last Updated 10/18/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083978019
Products in Payments
- FARXIGA (Drug) $543.63
- VRAYLAR (Drug) $467.44
- XARELTO (Drug) $422.26
- CHANTIX (Drug) $311.66
- LYRICA (Drug) $260.48
- JARDIANCE (Drug) $250.40
- XIFAXAN (Drug) $232.89
- Ozempic (Drug) $223.96
- Saxenda (Drug) $195.72
- JANUVIA (Drug) $187.58
- TRULICITY (Drug) $167.54
- TRELEGY ELLIPTA (Drug) $164.03
- INCRUSE (Drug) $143.19
- Aimovig (Biological) $126.80
- LINZESS (Drug) $125.76
- FREESTYLE LIBRE 2 (Device) $124.29
- ANORO (Drug) $120.92
- UBRELVY (Drug) $118.96
- Victoza (Drug) $113.02
- Prolia (Biological) $110.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Taylor Mill
Laura Foor, D.o, D.O
Family Medicine — Payments: $8,415
Dr. Stephanie Stirrat, M.d, M.D
Family Medicine — Payments: $7,079
Philip Hartman, M.d, M.D
Family Medicine — Payments: $6,418
Dr. Esther Saalfeld, Md, MD
Family Medicine — Payments: $5,870
Kevin Feeley, Do, DO
Family Medicine — Payments: $1,147
Alissa Lenz-Laporta, Do, DO
Family Medicine — Payments: $243.23